Comparative genome-wide analysis of gastric adenocarcinomas with hyperplastic polyp components.
Adenocarcinoma
/ pathology
Adenomatous Polyps
/ pathology
Aged
Aged, 80 and over
Cell Transformation, Neoplastic
/ pathology
Comparative Genomic Hybridization
/ methods
DNA Copy Number Variations
/ genetics
Female
Genome-Wide Association Study
/ methods
Humans
Hyperplasia
Intestinal Polyps
/ pathology
Polymorphism, Single Nucleotide
/ genetics
Polyps
/ pathology
Stomach Neoplasms
/ genetics
Tumor Suppressor Protein p53
/ genetics
Adenocarcinoma
Array comparative genomic hybridization
Hyperplastic polyp
Malignant transformation
Targeted amplicon sequencing
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
02
2019
accepted:
03
06
2019
revised:
06
04
2019
pubmed:
30
6
2019
medline:
4
9
2019
entrez:
29
6
2019
Statut:
ppublish
Résumé
Gastric hyperplastic polyps are common and generally regarded as benign lesions, whereas gastric adenocarcinomas infrequently occur from gastric hyperplastic polyps. Although gastric hyperplastic polyps have received a lot of attention because of their association with malignant transformation, it remains unclear whether gastric hyperplastic polyps are neoplastic lesions that have sporadic genetic changes similar to colorectal hyperplastic polyps. We performed genome-wide analyses of two gastric adenocarcinomas with hyperplastic polyp components. The interface between "adenocarcinoma" and "hyperplastic polyp" components was fairly sharp, and the adenocarcinoma components had copy number alterations and TP53 mutations, whereas the hyperplastic polyp components had only single nucleotide polymorphisms, which were also found in adenocarcinoma components. We did not detect any somatic changes in the hyperplastic polyp components, even in genome-wide analyses, which was in contrast to the adenocarcinoma components. However, due to the small number of cases examined herein, further genetic analyses of more cases are needed.
Identifiants
pubmed: 31250201
doi: 10.1007/s00428-019-02592-y
pii: 10.1007/s00428-019-02592-y
doi:
Substances chimiques
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
383-389Références
Hum Pathol. 2002 Oct;33(10):1016-22
pubmed: 12395375
Mol Pathol. 2003 Oct;56(5):293-8
pubmed: 14514924
Oncogene. 2005 Feb 17;24(8):1348-58
pubmed: 15608680
Dig Dis Sci. 2009 Sep;54(9):1839-46
pubmed: 19037727
Brain Pathol. 2010 Sep;20(5):936-44
pubmed: 20406234
World J Gastroenterol. 2014 Mar 14;20(10):2634-40
pubmed: 24627599
Oncol Lett. 2014 May;7(5):1459-1463
pubmed: 24765156
Exp Mol Pathol. 2015 Dec;99(3):468-73
pubmed: 26325218
Clin J Gastroenterol. 2017 Apr;10(2):128-136
pubmed: 28160247
Gastroenterology. 2019 Feb;156(3):647-661.e2
pubmed: 30342036
Lancet. 1983 Jan 1;1(8314-5):28-30
pubmed: 6129371
Brain Pathol. 1996 Jul;6(3):217-23; discussion 23-4
pubmed: 8864278
Gastroenterology. 1997 Feb;112(2):561-6
pubmed: 9024310